FDA Moves to Reduce Use of Opioid Containing Cough Meds

The FDA is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years of age.

“After safety labeling changes are made, these products will no longer be indicated for use to treat cough in any pediatric population and will be labeled for use only in adults aged 18 years and older,” the FDA announced in a press release. 

Labeling for the medications also is being updated with